Panodil Zapp

Panodil is a well-known brand of paracetamol-based painkillers, specifically marketed in Scandinavian and European regions. The 'Zapp' variant is formulated for faster absorption compared to standard tablets. The brand was originally developed and popularized by Sterling Winthrop, which was later acquired.

Today, Panodil is owned by Haleon, a major consumer healthcare company that was spun off from GlaxoSmithKline (GSK) in 2022. While the label in the image shows GSK Consumer Healthcare, the brand transitioned to Haleon ownership following the corporate demerger. Manufacturing for the Nordic market typically occurs in various European facilities depending on the specific batch and format.